483 Oxygen Development Jan 2018

483 Oxygen Development Jan 2018

Jennifer Huntington FDA$119.00 - Available Now

FDA investigators audited the Oxygen Development - Palm Springs, FL, United States facility and issued inspectional observations (via FDA 483) on 17 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jan 2018
  • Location: Palm Springs, United States
  • FEI: 3009461317
Add To Cart